<DOC>
	<DOCNO>NCT01677923</DOCNO>
	<brief_summary>The investigator hypothesize Metformin decrease weight , normalizes lipid profile increase insulin sensitivity ; study team hope get good effect weight decrease metabolic process repair intensive treatment group intervention physical activity , diet correction Metformin use .</brief_summary>
	<brief_title>Obesity Children Adolescents : Associated Risks Early Intervention</brief_title>
	<detailed_description>During first visit , study participant would follow clinical investigation ( anthropometry , physical examination , blood test ( hormonal biochemical state ) , bioimpedance , ultrasound evaluation ) attribute 4 group ( match age , gender , pubertal stage BMI ) , 100 subject group . 1. st group - control : first visit patient get standardize information healthy lifestyle , diet exercise . Next visit ( control ) schedule clinical laboratory evaluation 12 month intervention . 2. nd group - intensive diet physical activity group : Children see 1. dietician month diet re-evaluation ; 2. physical therapist , give physical activity course twice week ( 1 h ) . 3. pediatric endocrinologist every 3 month . Clinical laboratory evaluation 12 month intervention . 3. rd group - intensive diet physical activity group plus insulin sensitization : Metformin prescribe group study child dose 1000 mg/day Children see 1. dietician month diet re-evaluation ; 2. physical therapist , give physical activity course twice week ( 1 h ) ; 3. pediatric endocrinologist every 3 month . Clinical laboratory evaluation 12 month intervention . 4. th group- insulin sensitization without intensive diet physical activity . Metformin prescribe dos 1000 mg/day standardize information healthy lifestyle , diet exercise first visit . This group child see pediatric endocrinologist every 3 month . Intervention duration - 12 month . In case Metformin intolerance , child continue study 2nd group . Clinical laboratory evaluation 12 month intervention .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Age 1017 yr ; Weight &gt; 85th percentile age gender ( IOTF ) ; Living Kaunas region ; No obvious chronic disease ; Not steroid longterm treatment ; Informed consent patient parent ( official caregiver ) ; Age less 10 17 yr ; Diagnosis type 1 diabetes ; Chronic illness may affect physical activity metabolic profile ; Insulin treatment ; Steroid treatment ; Planning move Kaunas region period 1 year ; Protocol refuse patient parent ;</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>weight</keyword>
	<keyword>body mass index</keyword>
	<keyword>lipid profile</keyword>
	<keyword>glucose profile</keyword>
</DOC>